Owen B. Wallace

Insider Reports History

Entity: Individual
Location: C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
Signature: /s/ Markus Warmuth, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Owen B. Wallace:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Monte Rosa Therapeutics, Inc.	Chief Scientific Officer	Common Stock	5.27K	$100K	$19.00	Jan 2, 2024	Direct
Monte Rosa Therapeutics, Inc.	Chief Scientific Officer	Stock Option (Right to Buy)	119K			Jan 2, 2024	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Owen B. Wallace

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
GLUE	Monte Rosa Therapeutics, Inc.	Jan 2, 2024	1	$0	4	Jan 4, 2024	Chief Scientific Officer
GLUE	Monte Rosa Therapeutics, Inc.	Jan 3, 2023	1	$0	4	Jan 4, 2023	Chief Scientific Officer
GLUE	Monte Rosa Therapeutics, Inc.	Mar 1, 2022	1	$0	4	Mar 2, 2022	Chief Scientific Officer
GLUE	Monte Rosa Therapeutics, Inc.	Jun 23, 2021	0	$0	3	Jun 23, 2021	Chief Scientific Officer
GLUE	Monte Rosa Therapeutics, Inc.	Apr 12, 2021	2	$0	4	Jun 25, 2021	Chief Scientific Officer